President Donald Trump likely won’t do away with a landmark process that allows Medicare to negotiate drug prices with manufacturers, even as he moves to erase Joe Biden’s other historic policy accomplishments.
But Trump will likely make some changes to those price talks, and it may not require help from Congress.
“Trump is looking to nibble around the edges of the law,” said Matthew Kupferberg, a partner in Frier Levitt’s Life Sciences Group, adding...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Greek